Breakthrough T1D Celebrates Approval of Tzield for Use in Young Children to Delay the Onset of Insulin-Dependent Type 1 Diabetes

B NEW YORK, April 22, 2026 /PRNewswire/ — Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, applauds today’s…
posteditor
posteditor
Articles: 21727

Other News